Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery

被引:165
作者
Kimura, Niko [1 ]
Maeki, Masatoshi [2 ]
Sato, Yusuke [3 ]
Note, Yusuke [3 ]
Ishida, Akihiko [2 ]
Tani, Hirofumi [2 ]
Harashima, Hideyoshi [3 ]
Tokeshi, Manabu [2 ,4 ,5 ,6 ]
机构
[1] Hokkaido Univ, Grad Sch Chem Sci & Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan
[2] Hokkaido Univ, Fac Engn, Div Appl Chem, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan
[3] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12 Nishi 8, Sapporo, Hokkaido 0600812, Japan
[4] Nagoya Univ, ImPACT Res Ctr Adv Nanobiodevices, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan
[5] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan
[6] Nagoya Univ, Innovat Res Ctr Prevent Med Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan
关键词
MICROFLUIDIC DEVICES; SIRNA; MICROMIXERS; LIPOSOME; VESICLES; SYSTEMS; MIXER;
D O I
10.1021/acsomega.8b00341
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The precise size control of the lipid nanoparticle (LNP)-based nanodrug delivery system (DDS) carriers, such as 10 nm size tuning of LNPs, is one major challenge for the development of next-generation nanomedicines. Size-controlled LNPs would realize size-selective tumor targeting and deliver DNA and RNA to target tumor tissues effectively by passing through the stromal cells. Herein, we developed a baffle mixer device named the invasive lipid nanoparticle production device, or iLiNP device for short, which has a simple two-dimensional microchannel and mixer structure, and we achieved the first reported LNP size tuning at 10 nm intervals in the size range from 20 to 100 nm. In comparison with the conventional LNP preparation methods and reported micromixer devices, our iLiNP device showed better LNP size controllability, robustness of device design, and LNP productivity. Furthermore, we prepared 80 nm sized LNPs with encapsulated small interfering RNA (siRNA) using the iLiNP device; these LNPs effectively performed as nano-DDS carriers in an in vivo experiment. We expect iLiNP devices will become novel apparatuses for LNP production in nano-DDS applications.
引用
收藏
页码:5044 / 5051
页数:8
相关论文
共 29 条
[1]   Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA [J].
Belliveau, Nathan M. ;
Huft, Jens ;
Lin, Paulo J. C. ;
Chen, Sam ;
Leung, Alex K. K. ;
Leaver, Timothy J. ;
Wild, Andre W. ;
Lee, Justin B. ;
Taylor, Robert J. ;
Tam, Ying K. ;
Hansen, Carl L. ;
Cullis, Pieter R. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1 :e37
[2]  
Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/NNANO.2011.166, 10.1038/nnano.2011.166]
[3]   Liposome production by microfluidics: potential and limiting factors [J].
Carugo, Dario ;
Bottaro, Elisabetta ;
Owen, Joshua ;
Stride, Eleanor ;
Nastruzzi, Claudio .
SCIENTIFIC REPORTS, 2016, 6
[4]   Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation [J].
Chen, Delai ;
Love, Kevin T. ;
Chen, Yi ;
Eltoukhy, Ahmed A. ;
Kastrup, Christian ;
Sahay, Gaurav ;
Jeon, Alvin ;
Dong, Yizhou ;
Whitehead, Kathryn A. ;
Anderson, Daniel G. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (16) :6948-6951
[5]   Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration [J].
Chen, Sam ;
Tam, Yuen Yi C. ;
Lin, Paulo J. C. ;
Leung, Alex K. K. ;
Tam, Ying K. ;
Cullis, Pieter R. .
JOURNAL OF CONTROLLED RELEASE, 2014, 196 :106-112
[6]   Polymer therapeutics-prospects for 21st century: The end of the beginning [J].
Duncan, Ruth ;
Vicent, Maria J. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :60-70
[7]   High-Throughput Continuous Flow Production of Nanoscale Liposomes by Microfluidic Vertical Flow Focusing [J].
Hood, Renee R. ;
DeVoe, Don L. .
SMALL, 2015, 11 (43) :5790-5799
[8]   Preparation of nanoparticles by continuous-flow microfluidics [J].
Jahn, Andreas ;
Reiner, Joseph E. ;
Vreeland, Wyatt N. ;
DeVoe, Don L. ;
Locascio, Laurie E. ;
Gaitan, Michael .
JOURNAL OF NANOPARTICLE RESEARCH, 2008, 10 (06) :925-934
[9]   Microfluidic Mixing and the Formation of Nanoscale Lipid Vesicles [J].
Jahn, Andreas ;
Stavis, Samuel M. ;
Hong, Jennifer S. ;
Vreeland, Wyatt N. ;
Devoe, Don L. ;
Gaitan, Michael .
ACS NANO, 2010, 4 (04) :2077-2087
[10]   Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems [J].
Kraft, John C. ;
Freeling, Jennifer P. ;
Wang, Ziyao ;
Ho, Rodney J. Y. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (01) :29-52